Patrick Harrington (@drpharrington) header
Patrick Harrington (@drpharrington) profile picture

Haematologist and researcher based in London. Interests in myeloid neoplasms, immunohaematology and the Arsenal.

London, England
Joined April 2021
Photo by Patrick Harrington (@drpharrington)
Very pleased to share our work on development of natural language processing pipeline to assess cardiovascular risk and thrombotic complications in MPN. Machine learning approach allowing assessment of health records of >900 patients and >23000 documents onlinelibrary.wiley.com/doi/…
3
7
1
27
1,995
Patrick Harrington retweeted
Proud to share our recent study published on Leukaemia. QRISK3 score can identify MPN patients with higher risk of TE based on CV risk factors that may benefit of early cytoreduction nature.com/articles/s41375-0… @drpharrington @harrisoncn1
1
5
111
Patrick Harrington retweeted
The kids are alright.
1,225
19,345
1,603
114,672
3,430,524
Analysis highlighted increased thrombotic risk in PV patients compared with ET and identified hypertension as comorbidity of particular significance for VTE and CVA. Excellent work from @ADuminuco and Josh Au Yeung on getting this project completed.
1
5
178
Huge potential for future utilisation of NLP in research and healthcare setting @harrisoncn1 @KordastiL @PriyaSriRajah @DeeptiRadia @MPNVoice @G_ICEMD
3
165
Out now in @Haematologica our paper on effects of TKIs on T cell signalling in patients with chronic myeloid leukaemia. haematologica.org/article/vi… Dasatinib inhibits TCR and STAT5 signalling and inhibits T cell effector function cf. other TKIs. 1/3
1
7
1,145
- immunostimulatory effects of dasatinib potentially explained by preferential inhibition of Treg TCR signalling cf effector cells - pts with clonal CD8+ lymphocytosis also show greater inhibition of Treg signalling, may explain improved leukaemia related outcomes in this group
1
2
347
- STAT5 inhibition by dasatinib dependent on reduction in IL-2 - TIM3+ cells show increase TCR signalling in pts on other TKI 2/3 Thanks to support from @dr_de_Lavallade @DillonHaem @DeeptiRadia @DrLornan @SKordasti @harrisoncn1 and all participating patients and families 3/3
1
3
478
sciencedirect.com/science/ar… Finally in print @BloodAdvances, data showing importance of third dose of vaccine for Omicron variant neutralisation as well as increased T cell response against Covid-19 in patients with #MPNsm and #CMLsm
2
429
Patrick Harrington retweeted
Blood transfusion clinical fellow required to join the team ⁦@KHPHaematology⁩ ⁦@GSTTnhs⁩ ⁦@KingsCollegeNHS⁩ to look at data driven transfusion practice in partnership with the ⁦@DataDrivenBTRU⁩ team healthjobsuk.com/job/UK/Lond…
Increased immune checkpoint expression also seen in patients with refractory disease. Significant increase in plasma pro-inflammatory cytokines at diagnosis. Likely due to LAA overload with increased disease burden. Potential future role for checkpoint inhibitor therapy? 2/2
1
Other key findings include reduced response in patients receiving ChAdOx-1 vaccine after 2 doses. Presence of comorbidities also associated with reduced antibody response on multivariate analysis.
1
1
Many thanks to all patients who have participated in our study and to @bloodcancer_uk @BloodCancer_Res @MPNVoice for support Updated results from study due shortly… #MPNsm #CMLsm
4
Frequency and prognostic impact of blood-circulating tumor mast cells in mastocytosis loom.ly/L8B3hAQ
1
6
1
22
Patrick Harrington retweeted
A 2nd report today from @ljiresearch also demonstrates vaccination induced T-cells vs Omicron (B.1.1,519) well preserved compared with all variants and with 3 different vaccines biorxiv.org/content/10.1101/… @aetarke @SetteLab
Our T cells appear to be ready, willing and able to defend vs Omicron medrxiv.org/content/10.1101/… CD4+ and CD8+ cells hold up well in people vaccinated or prior Covid
18
253
48
804
Looking forward to presenting updated results from our study on #COVID19 vaccination in MPN, CML and alloSCT pts at #ASH2021. Pleased our work has been recognised with an abstract achievement award on consecutive years! #mpnsm #bmtsm #cmlsm
2
3
2
45
Pleased to report our paper is now published in @Cancer_Cell showing importance of repeated doses of SARS-CoV-2 vaccine for both T cell + Ab response in alloSCT pts. Grateful for support from patients, @bloodcancer_uk and team at @G_ICEMD @GSTTresearch authors.elsevier.com/a/1d-3y…
4
3
2
27